Break, TJ, Oikonomou, V, Dutzan, N, Desai, JV, Swidergall, M, Freiwald, T, Chauss, D, Harrison, OJ, Alejo, J
, Williams, DW, Pittaluga, S, Lee, C-CR, Bouladoux, N, Swamydas, M, Hoffman, KW, Greenwell-Wild, T, Bruno, VM, Rosen, LB, Lwin, W, Renteria, A, Pontejo, SM, Shannon, JP, Myles, IA, Olbrich, P, Ferré, EMN, Schmitt, M, Martin, D, Core16, GACB, Barber, DL, Solis, NV, Notarangelo, LD, Serreze, DV, Matsumoto, M, Hickman, HD, Murphy, PM, Anderson, MS, Lim, JK, Holland, SM, Filler, SG, Afzali, B, Belkaid, Y, Moutsopoulos, NM & Lionakis, MS 2021, '
Aberrant type 1 immunity drives susceptibility to mucosal fungal infections',
Science.
https://doi.org/10.1126/science.aay5731